2025-08-26 - Analysis Report
Okay, here's an analysis report for Teladoc Health Inc (TDOC) based on the provided data.

**Report: Teladoc Health Inc (TDOC) Analysis**

**0. Executive Summary**

This report analyzes the performance of Teladoc Health Inc (TDOC) against the S&P 500 (VOO), examining its stock performance, risk indicators, recent news, and financial data. The analysis reveals significant underperformance compared to the S&P 500, volatile stock behavior, and concerning profitability metrics.

**1. Performance vs. S&P 500 (VOO)**

*   **Company Overview:** Teladoc Health Inc. is a telehealth company offering virtual healthcare services.
*   **TDOC Cumulative Return:** -64.26%
*   **VOO Cumulative Return:** 38.06%
*   **Performance Spread:**  -102.32% (TDOC significantly underperforms VOO)
*   **Spread Metrics:** Max: 509.2, Min: -104.0, Current: -103.0, Relative Spread: 0.2

**Analysis:** The substantial negative performance spread indicates that TDOC has severely underperformed the S&P 500. The relative spread of 0.2 suggests that TDOC's current underperformance is near its worst historical levels compared to the S&P 500.

*   **Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
|------------|----------|----------|----------|--------|--------|
| 2015-2017  | 76.0%    | 60.6%    | 76.0%    | 1.0    | 6.2    |
| 2016-2018  | 128.0%   | 59.3%    | 128.0%   | 1.0    | 8.8    |
| 2017-2019  | 176.0%   | 59.3%    | 176.0%   | 1.0    | 14.8   |
| 2018-2020  | 237.0%   | 64.0%    | 237.0%   | 1.0    | 35.3   |
| 2019-2021  | -83.0%   | 64.0%    | -84.0%   | -0.0   | 16.2   |
| 2020-2022  | -295.0%  | 81.3%    | -284.0%  | -0.0   | 4.2    |
| 2021-2023  | -488.0%  | 81.3%    | -498.0%  | 0.0    | 3.8    |
| 2022-2024  | -111.0%  | 81.3%    | -141.0%  | 0.0    | 1.6    |
| 2023-2025  | -35.0%   | 75.5%    | -79.0%   | 0.0    | 1.4    |

**Analysis:**

*   **CAGR and MDD:** The table shows a significant decline in CAGR (Compound Annual Growth Rate) and high MDD (Maximum Drawdown) in recent years, indicating poor investment performance and high risk.
*   **Alpha:** Negative alpha values from 2019 onwards indicate that TDOC has consistently underperformed its benchmark.
*   **Beta:** Beta values close to zero suggest that TDOC's price movements are not strongly correlated with the overall market.
*   **Cap(B):** The market capitalization has decreased significantly, reflecting a loss of investor confidence.

**2. Recent Stock Price Movement**

*   **Current Price:** $7.67
*   **Last Market Data:** Price: $7.67, Previous Close: $7.68, Change: -0.13
*   **5-Day Moving Average:** 7.42
*   **20-Day Moving Average:** 7.22
*   **60-Day Moving Average:** 7.62

**Analysis:** The current price is slightly below the previous close and slightly above the 60-day moving average but above the 5-day and 20-day moving averages. This suggests a potential short-term upward trend, but the small price change of -0.13 does not indicate any significant volatility events.

**3. Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.32 (Low Risk)
*   **RSI:** 66.82 (Approaching overbought territory)
*   **PPO:** 1.01
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.32)
*   **Recent (20-day) Relative Spread Change:** 0.1 (Positive - short-term increase)
*   **Expected Return:** -4462.8% (Long-term underperformance vs. S&P 500)

**Analysis:**

*   The MRI indicates low market risk.
*   The RSI suggests the stock might be approaching overbought conditions, potentially indicating a need for caution.
*   The positive change in relative spread shows a short-term increase in TDOC's performance relative to the S&P 500.
*   **Caution:** The extremely negative expected return highlights significant concerns about the long-term investment potential of TDOC compared to the S&P 500.

**4. Recent News & Significant Events**

*   **[2025-08-25]:** Major business developments, regulatory changes, or market events affecting TDOC.
*   **[2025-08-22]:** Analysts discussing TDOC's recent performance and outlook.
*   **[2025-08-23]:** TDOC's stock showing notable volatility.
*   **[2025-08-24]:** Market experts highlight both risks and opportunities for TDOC.

**Analysis:** Recent news indicates that TDOC is experiencing volatility and is subject to significant market discussion and analysis. Investors should monitor these developments closely.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-07-30 | -0.19 | 0.63 B$    |
| 2025-05-01 | -0.53 | 0.63 B$    |
| 2024-10-31 | -0.19 | 0.64 B$    |
| 2024-08-01 | -4.92 | 0.64 B$    |
| 2025-07-30 | -4.92 | 0.64 B$    |

**Analysis:** The consistent negative EPS (Earnings Per Share) values are concerning. While revenue has remained relatively stable around $0.63-0.64 billion, the inability to generate positive earnings is a significant red flag.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|----------------|
| 2025-06-30   | $0.63B    | 69.85%         |
| 2025-03-31   | $0.63B    | 68.73%         |
| 2024-12-31   | $0.64B    | 70.50%         |
| 2024-09-30   | $0.64B    | 71.94%         |
| 2024-06-30   | $0.64B    | 70.73%         |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-06-30   | $1.42B    | -2.30%    |
| 2025-03-31   | $1.43B    | -6.52%    |
| 2024-12-31   | $1.49B    | -3.25%    |
| 2024-09-30   | $1.51B    | -2.21%    |
| 2024-06-30   | $1.50B    | -55.77%   |

**Analysis:**

*   **Profit Margin:** While the profit margins appear high, it's important to note that these margins might not reflect the true profitability of the company due to potential accounting practices (e.g., non-GAAP measures).
*   **ROE:** The negative Return on Equity (ROE) values indicate that the company is not generating profits from its equity. The significant drop in ROE in 2024-06-30 is particularly concerning.
*   **Equity:** Declining equity suggests potential financial distress.

**7. Comprehensive Analysis**

Based on the provided data, Teladoc Health Inc (TDOC) exhibits several concerning factors:

*   **Significant Underperformance:**  TDOC has significantly underperformed the S&P 500 over the analyzed period.
*   **Negative Profitability:**  Consistent negative EPS and ROE indicate that the company is struggling to generate profits.
*   **High Risk:** High MDD values indicate significant investment risk.
*   **Volatile Stock Behavior:** Recent news highlights ongoing stock volatility.
*   **Declining Financial Health:** Declining equity suggests a weakening financial position.
*   **Long-Term Concerns:** Extremely negative expected return suggests fundamental issues in the company's long-term performance potential.

**Conclusion:**

This analysis suggests a cautious approach to investing in TDOC. The company's underperformance, negative profitability, and high risk profile warrant careful consideration. Investors should conduct further due diligence and monitor company announcements and market news closely.
